Venous vascular prosthesis GORE® ACUSEAL

synthetic

For hemodialysis patients, a "fistula first" approach has long been the standard. But fistulas can fail, 20 to 60 percent of the time,1-5 subjecting patients to undue hardship and central venous catheter (CVC)-related risks. That's one reason 2019 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines6 emphasize the need for a more individualized approach to access modality selection. It is about achieving the "right access, in the right patient, at the right time, for the right reasons." - KDOQI guidelines When patients are at risk for fistula non-maturation, turn to the GORE® ACUSEAL Vascular Graft – the purpose-built choice for rapid and long-term access for the road ahead. It is ideal for patients who are already on a CVC, or those who need a new access and must achieve cannulation in under two weeks. It allows for earlier removal or avoidance of a CVC and helps achieve hemodialysis success with minimized access-related procedures and complications ─ for more confidence at every step. LOWER TOTAL COST OF CARE: Reduces the cost of treating CVC sepsis by allowing for earlier removal of CVCs.*,10 Designed with your patients in mind Because dialysis access is personal The tri-layer design of the GORE® ACUSEAL Vascular Graft is optimized for early cannulation and provides uncompromised handling. Purpose-built for immediate cannulation, designed with an elastomeric middle layer that serves as a low bleed barrier to cannulation needle holes. Flexible at curves without kinking. The GORE® ACUSEAL Vascular Graft also features CBAS® Heparin Surface technology to resist thrombosis ─ a leading cause of AVG failure.11